Molecular Partners (MOLN) Earnings Date, Estimates & Call Transcripts $3.80 +0.23 (+6.28%) As of 01:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Molecular Partners Earnings Summary Molecular Partners issued H1 2025 earnings on August 25, 2025, reporting an EPS of -$0.67, which missed analysts' consensus estimates of -$0.53 by $0.14. With a trailing EPS of -$2.08, Molecular Partners' earnings are expected to decrease next year, from ($1.93) to ($2.08) per share. Upcoming Earnings DateOct. 30After Market ClosesEstimatedConsensus EPS (Aug. 25) -$0.53 Actual EPS (Aug. 25) -$0.67 Missed By -$0.14 H1 2025 Earnings ResourcesH1 2025 Earnings Report Press Release (8-K)MOLN Upcoming EarningsMolecular Partners' next earnings date is estimated for Thursday, October 30, 2025, based on past reporting schedules. Powered by Get Molecular Partners Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Molecular Partners and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataMOLN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MOLN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Molecular Partners Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$0.53-$0.53-$0.53 Molecular Partners Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 10/30/2025(Estimated)--------8/25/2025H1 2025-$0.53-$0.67 -$0.14-$0.67--5/15/2025Q1 2025-$0.3855-$0.50 -$0.1145-$0.50--3/6/2025H2 2024-$0.45-$0.34+$0.11-$0.34--10/31/2024--$0.63-$0.57+$0.06-$0.57-$0.79M8/26/2024H1 2024--$0.51--$0.51-$1.72M5/16/2024Q1 2024--$0.39--$0.39-$3.13M3/14/2024H2 2023--$0.68--$0.68-$1.17M10/26/2023Q3 2023--$0.40--$0.40-$2.88M Molecular Partners Earnings - Frequently Asked Questions When is Molecular Partners' earnings date? Molecular Partners has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based off last year's report dates. Learn more on MOLN's earnings history. Did Molecular Partners beat their earnings estimates last quarter? In the previous quarter, Molecular Partners (NASDAQ:MOLN) missed the analysts' consensus estimate of ($0.53) by $0.14 with a reported earnings per share (EPS) of ($0.67). Learn more on analysts' earnings estimate vs. MOLN's actual earnings. How much revenue does Molecular Partners generate each year? Molecular Partners (NASDAQ:MOLN) has a recorded annual revenue of $5.65 million. How much profit does Molecular Partners generate each year? Molecular Partners (NASDAQ:MOLN) has a recorded net income of -$61.39 million. MOLN has generated -$2.08 earnings per share over the last four quarters. What is Molecular Partners' EPS forecast for next year? Molecular Partners' earnings are expected to decrease from ($1.93) per share to ($2.08) per share in the next year. More Earnings Resources from MarketBeat Related Companies Tourmaline Bio Earnings Results Siga Technologies Earnings Results Palvella Therapeutics Earnings Results MeiraGTx Earnings Results Xencor Earnings Results AnaptysBio Earnings Results Arvinas Earnings Results Savara Earnings Results Gossamer Bio Earnings Results Oruka Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why DocuSign Could Be a SaaS Value Play After Q2 EarningsAffirm Crushes Earnings Expectations, Turns Bears into BelieversAmbarella's Earnings Prove Its Edge AI Strategy Is a WinnerWhat to Watch for From D-Wave Now That Earnings Are DoneDICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples Play This page (NASDAQ:MOLN) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MOLN Stock Alerts